ASHP Foundation Pharmacy Forecast 2020: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems. Impact of Ideal Body Weight Dosing for all Inpatient I.V. Catch up on interviews with pharmacy leaders, good news segments, member stories, and more, on ASHP TV. ASHP Expert Panel on Drug Product Shortages, Fox ER, Birt A, James KB, Kokko H, Salverson S, Soflin DL. Orthopedics. Drug shortages: a complex health care crisis. IVIG is an essential therapy for the treatment of many debilitating and/or life-threatening immunodeficiency and immune dysregulatory disorders. « Back to Drug Shortage Product Bulletins. Small-Volume Parenteral Solutions Shortages: Suggestions for Management and Conservation (PDF - 153 KB). Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward. Am J Health Syst Pharm. November 26, and December 10, 2018; January 17, February 11, March 20, April 24, and November 20, 2019; January 29, April 6, and June 26, 2020. Check back frequently as new jobs are posted every day. ADMA Biologics (personal communication). Rocchio MA, Hussey AP, Southard RA, Szumita PM. Octapharma (personal communication). The authors have declared no other potential conflicts of interest. Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages. * Ensure the dose and interval are appropriate. ASPEN is continually addressing the ongoing shortage of PN components by working with and maintaining communications with the FDA, pharmaceutical manufacturers, other professional healthcare organizations and clinicians to stay up to date on the status of shortages, collaborate to resolve shortages and to provide resources for managing shortages. eCollection 2020. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Please enable it to take advantage of the complete set of features! Kedrion (personal communication). An analysis of the Northern Navajo Medical Center (NNMC) found that although opportunities grew due to provider shortages, pharmacists practicing at the top of their license have the ability to significantly improve access to care, particularly in areas revolving around medication management, according to a poster presented at the American Society of Health-System Pharmacists' (ASHP) virtual 2020 ASHP … Government intervention. Advertisement. eCollection 2020. 2020 Jan 8;77(2):84-112. doi: 10.1093/ajhp/zxz283. [1-2], CSL Behring is releasing Hizentra and Privigen regularly and distributors are allocating product. ASHP guidelines on managing drug product shortages. Learn more Residency Program Design and Conduct Virtual Workshops. Mallhi TH, Liaqat A, Abid A, Khan YH, Alotaibi NH, Alzarea AI, Tanveer N, Khan TM. January … Boyle said the IVIg shortage will not end soon, but he encouraged the public to consider donating blood plasma. As such, we have high hopes we're going to see a lot of advancement of indications in 2018 and some new products being released. Fox is a member of the AJHP Editorial Board. 2020 May 12;7:157. doi: 10.3389/fmed.2020.00157. There is … National drug shortages statistics and their interpretation. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. However, some manufacturers may not have all presentations available. Drug product shortages can adversely affect drug therapy, compromise or delay medical procedures, result in medication errors, and cause patient harm.1–38 In addition to these potential problems, healthcare professionals are also increasingly concerned about the tremendous resources required to address shortages, estimated at $209 million in 2013 for the purchase of more-expensive substitutes alone, which excludes other significant costs (e.g., drugs purchased “off contract,” therapeutic alternativ… 2013.  |  Vermeulen LC, Swarthout MD, Alexander GC, Ginsburg DB, Pritchett KO, White SJ, Tryon J, Emmerich C, Nesbit TW, Greene W, Fox ER, Conti RM, Scott BE, Sheehy F, Melby MJ, Lantzy MA, Hoffman JM, Knoer S, Zellmer WA. ASHP has gathered guidance, tools, and background information to help pharmacists maintain effective patient care. 2015. McBride A, Holle LM, Westendorf C, Sidebottom M, Griffith N, Muller RJ, Hoffman JM. November 26, 2018; March 20 November 20, 2019; January 29, April 20, June 11, and August 28, 2020. Stump SE, Schepers AJ, Jones AR, et al. [8], Immune globulin products are life-saving and critical products for a number of acute and chronic conditions including, but not limited to: B-cell chronic lymphocytic leukemia, chronic inflammatory demyelinating polyneuropathy, idiopathic thrombocytopenic purpura, Kawasaki disease, and primary immunodeficiency diseases.[9]. In: McEvoy GK, Snow EK, eds. [5], Octapharma has Cutaquig and Octagam available. You might need to discuss other treatment options with their providers, which may include plasmapheresis or immunosuppressant medications. Am J Health Syst Pharm. Chest. [3], Grifols has Gamunex-C, Flebogamma, and Xembify available. Explore. NLM American Society of Health-System Pharmacists (ASHP) - Find your next career at ASHP CareerPharm. Let them know when your symptoms start to escalate. ASHP Supports the Mitigating Emergency Drug Shortages (MEDS) Act [10/28/19] Drug Shortage Legislative Objectives [08/28/19] ASHP Applauds Senators and Expresses Support for Drug Shortages Task Force [06/21/19] ASHP Letter to Leaders of the Oversight and Investigations Subcommittee on Shortage of Small-Volume Parenteral Solutions [11/9/17] Notifying ASHP or FDA about a drug product shortage can initiate these efforts. Data are available regarding dosing using ideal or adjusted body weight.[10-12]. Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. November 5, 2020. Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.  |  2020 Jul;27(4):202-208. doi: 10.1136/ejhpharm-2020-002341. 72(4):285-289. Am J Health Syst Pharm. 70(9): 751-752. Correlation of Weight-Based I.V. ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems. Miljković N, Batista A, Polidori P, Kohl S, Horák P. Eur J Hosp Pharm. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. ASHP guidelines on managing drug product shortages Am J Health Syst Pharm. Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals. The supplement can be found at: https://academic.oup.com/ajhp/issue/62/16_Supplement_3. Front Med (Lausanne). Am J Health Syst Pharm. One manufacturer is even looking at utilizing intravenous immune globulin (IVIG) to treat some of the more rare autoimmune disorders such as encephalitis and PANS/PANDAS. AHFS 2019 Drug Information. Grifols (personal communication). Front Med (Lausanne). CSL Behring (personal communication). Immune Globulin. This site needs JavaScript to work properly. 2020 Dec 8;8:561924. doi: 10.3389/fpubh.2020.561924. This year, changes were made to adapt to the coronavirus disease 2019 (COVID-19) pandemic in order to continue to allow 340B stakeholders to have access to the PV’s distribution, education, and general assistance resources during the pandemic, according to a session at the 2020 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition. On November 11, 2017, ASHP convened a roundtable of government and non-profit drug shortages stakeholders. According to the American Society of Health-System Pharmacists (ASHP) and the American Hospital Association (AHA), the Coronavirus Aid, Relief, and Economic Security (CARES) Act offers some provisions that address shortages of drugs and medical devices. National Center for Biotechnology Information, Unable to load your collection due to an error, Unable to load your delegates due to an error. Miljković N, Godman B, van Overbeeke E, Kovačević M, Tsiakitzis K, Apatsidou A, Nikopoulou A, Yubero CG, Portillo Horcajada L, Stemer G, Kuruc-Poje D, De Rijdt T, Bochenek T, Huys I, Miljković B. eCollection 2020. 2017;12:1530-1536. 2011 Sep;34(9):712-4. doi: 10.3928/01477447-20110714-15. Burry LD, Barletta JF, Williamson D, Kanji S, Maves RC, Dichter J, Christian MD, Geiling J, Erstad BL. At that time, many hospitals had their Pharmacy & Therapeutics Committees establish strategies to prioritize the IVIG available to hospital pharmacies. Comparison of Weight-Based Dosing Strategies for Intravenous Immunoglobulin in Patients with Hematologic Malignancies. It Takes a Village…: Contending With Drug Shortages During Disasters. [6], Takeda has Gammagard on shortage due to increased demand. BioCare SD (personal communication). This report summarizes the presentations, discussion, and … Anderson CR, Olson JA. Coronavirus Disease (COVID-19): The FDA continues to take steps to monitor the supply chain. 2009 Aug 1;66(15):1399-406. doi: 10.2146/ajhp090026. Managing Drug Shortages. Immune Globulin Indications. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Immune Globulin, Intravenous or Subcutaneous (Human), Bivigam solution for injection, ADMA Biologics, Immune globulin (human) 10%, 5 gram protein/50 mL bottle, NDC 59730-6502-01, Flebogamma DIF solution for injection, Grifols, Intravenous Immune globulin (human) 10%, 10 grams protein/100 mL vial, NDC 69153-0005-02, Flebogamma DIF solution for injection, Grifols, Intravenous Immune globulin (human) 10%, 20 grams protein/200 mL vial, NDC 69153-0005-03, Flebogamma DIF solution for injection, Grifols, Intravenous Immune globulin (human) 10%, 5 grams protein/50 mL vial, NDC 69153-0005-01, Flebogamma DIF solution for injection, Grifols, Intravenous Immune globulin (human) 5%, 0.5 grams protein/10 mL vial, NDC 69153-0004-01, Flebogamma DIF solution for injection, Grifols, Intravenous Immune globulin (human) 5%, 10 grams protein/200 mL vial, NDC 69153-0004-04, Flebogamma DIF solution for injection, Grifols, Intravenous Immune globulin (human) 5%, 2.5 grams protein/50 mL vial, NDC 69153-0004-02, Flebogamma DIF solution for injection, Grifols, Intravenous Immune globulin (human) 5%, 20 grams protein/400 mL vial, NDC 69153-0004-05, Flebogamma DIF solution for injection, Grifols, Intravenous Immune globulin (human) 5%, 5 grams protein/100 mL vial, NDC 69153-0004-03, Gammagard Liquid solution for injection, Takeda, Immune globulin (human) 10%, 1 gram protein/10 mL bottle, NDC 00944-2700-02, Gammagard Liquid solution for injection, Takeda, Immune globulin (human) 10%, 10 gram protein/100 mL bottle, NDC 00944-2700-05, Gammagard Liquid solution for injection, Takeda, Immune globulin (human) 10%, 2.5 gram protein/25 mL bottle, NDC 00944-2700-03, Gammagard Liquid solution for injection, Takeda, Immune globulin (human) 10%, 20 gram protein/200 mL bottle, NDC 00944-2700-06, Gammagard Liquid solution for injection, Takeda, Immune globulin (human) 10%, 30 gram protein/300 mL bottle, NDC 00944-2700-07, Gammagard Liquid solution for injection, Takeda, Immune globulin (human) 10%, 5 gram protein/50 mL bottle, NDC 00944-2700-04, Gammaked solution for injection, Kedrion Biopharma, Inc., Intravenous or subcutaneous Immune globulin (human) 10%, 1 gram protein/10 mL vial, NDC 76125-0900-01, Gammaked solution for injection, Kedrion Biopharma, Inc., Intravenous or subcutaneous Immune globulin (human) 10%, 10 gram protein/100 mL vial, NDC 76125-0900-10, Gammaked solution for injection, Kedrion Biopharma, Inc., Intravenous or subcutaneous Immune globulin (human) 10%, 2.5 gram protein/25 mL vial, NDC 76125-0900-25, Gammaked solution for injection, Kedrion Biopharma, Inc., Intravenous or subcutaneous Immune globulin (human) 10%, 20 gram protein/200 mL vial, NDC 76125-0900-20, Gammaked solution for injection, Kedrion Biopharma, Inc., Intravenous or subcutaneous Immune globulin (human) 10%, 5 gram protein/50 mL vial, NDC 76125-0900-50, Gamunex-C solution for injection, Grifols, Intravenous or subcutaneous Immune globulin (human) 10%, 1 gram protein/10 mL vial, NDC 13533-0800-12, Gamunex-C solution for injection, Grifols, Intravenous or subcutaneous Immune globulin (human) 10%, 10 grams protein/100 mL vial, NDC 13533-0800-71, Gamunex-C solution for injection, Grifols, Intravenous or subcutaneous Immune globulin (human) 10%, 2.5 grams protein/25 mL vial, NDC 13533-0800-15, Gamunex-C solution for injection, Grifols, Intravenous or subcutaneous Immune globulin (human) 10%, 20 grams protein/200 mL vial, NDC 13533-0800-24, Gamunex-C solution for injection, Grifols, Intravenous or subcutaneous Immune globulin (human) 10%, 40 grams protein/400 mL vial, NDC 13533-0800-40, Gamunex-C solution for injection, Grifols, Intravenous or subcutaneous Immune globulin (human) 10%, 5 grams protein/50 mL vial, NDC 13533-0800-20, Hizentra subcutaneous solution for injection, CSL Behring, Immune globulin (human) 20%, 1 gram protein/5 mL vial, NDC 44206-0451-01, Hizentra subcutaneous solution for injection, CSL Behring, Immune globulin (human) 20%, 10 grams protein/50 mL vial, NDC 44206-0455-10, Hizentra subcutaneous solution for injection, CSL Behring, Immune globulin (human) 20%, 2 grams protein/10 mL vial, NDC 44206-0452-02, Hizentra subcutaneous solution for injection, CSL Behring, Immune globulin (human) 20%, 4 grams protein/20 mL vial, NDC 44206-0454-04, Privigen 10% Liquid intravenous solution for injection, CSL Behring, Immune globulin (human) 10%, 100 mL / 10 gram protein bottle, NDC 44206-0437-10, Privigen 10% Liquid intravenous solution for injection, CSL Behring, Immune globulin (human) 10%, 200 mL / 20 gram protein bottle, NDC 44206-0438-20, Privigen 10% Liquid intravenous solution for injection, CSL Behring, Immune globulin (human) 10%, 400 mL / 40 gram protein bottle, NDC 44206-0439-40, Privigen 10% Liquid intravenous solution for injection, CSL Behring, Immune globulin (human) 10%, 50 mL / 5 gram protein bottle, NDC 44206-0436-05, Xembify solution for injection, Grifols, Subcutaneous Immune globulin (human) - klhw 20%, 1 gram protein/5 mL single dose vial, NDC 13533-0810-05, Xembify solution for injection, Grifols, Subcutaneous Immune globulin (human) - klhw 20%, 10 gram protein/50 mL single dose vial, NDC 13533-0810-50, Xembify solution for injection, Grifols, Subcutaneous Immune globulin (human) - klhw 20%, 2 gram protein/10 mL single dose vial, NDC 13533-0810-10, Xembify solution for injection, Grifols, Subcutaneous Immune globulin (human) - klhw 20%, 4 gram protein/20 mL single dose vial, NDC 13533-0810-20, ADMA Biologics has Bivigam on allocation through BioCare SD. What You Should Know. 2013 Apr 1;70(7):609-17. doi: 10.2146/ajhp120563. Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah, provided by ASHP as its exclusive authorized distributor, and used with permission. The American Journal of Health-System Pharmacy supplement on immune globulin may be helpful for clinicians. The American Society of Health-System Pharmacists (ASHP) has launched CareerPharm Rapid Connect, a new, free service to connect health care facilities with pharmacy personnel who can help alleviate potential staffing shortages during the coronavirus 2019 disease (COVID-19) pandemic. Use alternatives if available. Product switches may be inevitable during times of shortage. Bethesda, MD: American Society of Health-Systems Pharmacists; 2019: 3377-3397. [1-2], CSL Behring has Hizentra and Privigen on shortage due to increased demand. April 30, July 11, 2019; January 29, February 3, and April 6, 2020. Submitted information will be shared with ASHP's drug shortages team. Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. Results of EAHP's 2019 Medicines Shortages Survey. It is a searchable database that provides up-to-date information for consumers and healthcare professionals related to current drug shortages. Check out coverage of special events, educational sessions, awards, and more in News & Views, Midyear’s daily news publication. 2018 Nov 1;75(21):1742-1750. doi: 10.2146/ajhp180441. Takeda (personal communication). ASHP: Purpose: Provides information obtained from manufacturers about current shortages, estimated duration, and discontinuations and provides information about FDA’s and other stakeholders’ roles in addressing and preventing shortages: Notification of new shortages and status of ongoing shortages; drug shortage management resources: Audience: Public [4], Kedrion has Gammaked on allocation to its current customers. ASHP Expert Panel on Drug Product Shortages, et al. July 11, August 26, and September 24, 2019; April 6 and August 28, 2020. Immune Globulin Doses with Changes in Serum Immunoglobulin G levels. The ASHP Board of Directors Donald E. Francke Medal, which is awarded to a pharmacist who has made international contributions to the advancement of pharmacy practice, was awarded to Anthony Serracino-Inglott, PharmD. October 17, November 28, December 3, 2018; January 9 and 17, April 2, March 20, April 24, September 24, November 20, 2019; January 29, June 4 and 26, and August 28, 2020. National survey on the effect of oncology drug shortages on cancer care.  |  Am J Health Syst Pharm. However, according to both organizations, there’s more work to be done. [3], Grifols has Gamunex-C and Flebogamma available and distributors are allocating product. The American Society of Health-System Pharmacists (ASHP) lists every drug shortage reported through their online report form as soon as it is investigated and confirmed, usually within 24 to 72 hours. DisclosuresDr. Additional Information on Drug Shortages. So, if you’re facing an IVIG shortage, here’s my my patient-to-patient recommendation: Stay in continual communication with your prescribing provider. Front Public Health. 2014 Mar;89(3):361-73. doi: 10.1016/j.mayocp.2013.11.014. Yet IVIG’s complicated manufacturing process, its scientific uncertainty, and even certain financial motivations are just some of the nuanced factors leading to shortage of the drug, which is used for patients whose immune systems are compromised by viruses or cancer treatments. Two day residency program design and conduct workshops. Miljković N, van Overbeeke E, Godman B, Kovačević M, Anastasi A, Bochenek T, Huys I, Miljković B. NIH A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. Epub 2018 Jul 30. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. 2020 Aug 5;7:407. doi: 10.3389/fmed.2020.00407. Considering that previous Ig shortages, such as the ones in the late 1990s, had created similar predicaments, one would have expected hospitals and other centralized care systems to be thoughtful stewards of such a precious resource. Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. News & Views and ASHP TV. [4], Kedrion Biopharma has Gammaked available to current customers. Mayo Clin Proc. Epub 2020 Aug 14. Serracino-Inglott is a professor in the department of pharmacy, faculty of medicine and surgery at the University of Malta in Msida. FDA is responsible for assisting with drug product shortages … 2020 Dec;158(6):2414-2424. doi: 10.1016/j.chest.2020.08.015. Pharmacotherapy. This list differs from the FDA’s list as ASHP lists every drug shortage reported through their online report form as soon as it is investigated and confirmed, usually within 24-72 hours, whereas the FDA site focuses only on shortages of medically necessary drugs, as these have the potential to impact public health. Make every attempt to maintain consistent therapy when possible. Drawing attention to the shortage may encourage production by other manufacturers, collaborative efforts to develop alternative therapies, and ad hoc training opportunities on the safe and effective use of alternatives. Epub 2020 May 29. Interruptions in supply can present clinical and administrative challenges. * Ensure immune globulin is appropriate and necessary for the indication. [8], Asceniv solution for injection, ADMA Biologics, Immune globulin (human) - slra 10%, 5 gram protein/50 mL single dose vial, (available through Biocare SD) NDC 69800-0250-02, Cutaquig subcutaneous solution for injection, Octapharma, Subcutaneous Immune globulin (human) - hipp 16.5%, 1 gram protein/6 mL single dose vial, NDC 68982-0810-01, Cutaquig subcutaneous solution for injection, Octapharma, Subcutaneous Immune globulin (human) - hipp 16.5%, 1.65 gram protein/10 mL single dose vial, NDC 68982-0810-02, Cutaquig subcutaneous solution for injection, Octapharma, Subcutaneous Immune globulin (human) - hipp 16.5%, 2 gram protein/12 mL single dose vial, NDC 68982-0810-03, Cutaquig subcutaneous solution for injection, Octapharma, Subcutaneous Immune globulin (human) - hipp 16.5%, 3.3 gram protein/20 mL single dose vial, NDC 68982-0810-04, Cutaquig subcutaneous solution for injection, Octapharma, Subcutaneous Immune globulin (human) - hipp 16.5%, 4 gram protein/24 mL single dose vial, NDC 68982-0810-05, Cutaquig subcutaneous solution for injection, Octapharma, Subcutaneous Immune globulin (human) - hipp 16.5%, 8 gram protein/48 mL single dose vial, NDC 68982-0810-06, Cuvitru subcutaneous solution for injection, Takeda, Immune globulin (human) 20%, 1 gram protein/5 mL vial, NDC 00944-2850-01, Cuvitru subcutaneous solution for injection, Takeda, Immune globulin (human) 20%, 2 grams protein/10 mL vial, NDC 00944-2850-03, Cuvitru subcutaneous solution for injection, Takeda, Immune globulin (human) 20%, 4 grams protein/20 mL vial, NDC 00944-2850-05, Cuvitru subcutaneous solution for injection, Takeda, Immune globulin (human) 20%, 8 grams protein/40 mL vial, NDC 00944-2850-07, HyQvia subcutaneous solution for injection, Takeda, Immune globulin (human) 10% / Recombinant Human Hyaluronidase, 10 grams protein / 100 mL - 800 units / 5 mL dual vial, NDC 00944-2512-02, HyQvia subcutaneous solution for injection, Takeda, Immune globulin (human) 10% / Recombinant Human Hyaluronidase, 2.5 grams protein / 25 mL - 200 units / 1.25 mL dual vial, NDC 00944-2510-02, HyQvia subcutaneous solution for injection, Takeda, Immune globulin (human) 10% / Recombinant Human Hyaluronidase, 20 grams protein / 200 mL - 1600 units / 10 mL dual vial, NDC 00944-2513-02, HyQvia subcutaneous solution for injection, Takeda, Immune globulin (human) 10% / Recombinant Human Hyaluronidase, 30 grams protein / 300 mL - 2400 units / 15 mL dual vial, NDC 00944-2514-02, HyQvia subcutaneous solution for injection, Takeda, Immune globulin (human) 10% / Recombinant Human Hyaluronidase, 5 grams protein / 50 mL - 400 units / 2.5 mL dual vial, NDC 00944-2511-02, Octagam 10% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 10%, 100 mL / 10 gram protein bottle, NDC 68982-0850-03, Octagam 10% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 10%, 20 mL / 2 gram protein bottle, NDC 68982-0850-01, Octagam 10% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 10%, 200 mL / 20 gram protein bottle, NDC 68982-0850-04, Octagam 10% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 10%, 50 mL / 5 gram protein bottle, NDC 68982-0850-02, Octagam 5% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 5%, 100 mL / 5 gram protein bottle, NDC 68982-0840-03, Octagam 5% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 5%, 20 mL / 1 gram protein bottle, NDC 68982-0840-01, Octagam 5% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 5%, 200 mL / 10 gram protein bottle, NDC 68982-0840-04, Octagam 5% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 5%, 50 mL / 2.5 gram protein bottle, NDC 68982-0840-02, Octagam 5% Liquid intravenous solution for injection, Octapharma, Immune globulin (human) 5%, 500 mL / 25 gram protein bottle, NDC 68982-0840-05, Panzyga intravenous solution for injection, Pfizer, Immune globulin (human) - ifas -10%, 10 mL / 1 gram protein bottle, NDC 00069-1011-02, Panzyga intravenous solution for injection, Pfizer, Immune globulin (human) - ifas -10%, 100 mL / 10 gram protein bottle, NDC 00069-1312-02, Panzyga intravenous solution for injection, Pfizer, Immune globulin (human) - ifas -10%, 200 mL / 20 gram protein bottle, NDC 00069-1415-02, Panzyga intravenous solution for injection, Pfizer, Immune globulin (human) - ifas -10%, 25 mL / 2.5 gram protein bottle, NDC 00069-1109-02, Panzyga intravenous solution for injection, Pfizer, Immune globulin (human) - ifas -10%, 300 mL / 30 gram protein bottle, NDC 00069-1558-02, Panzyga intravenous solution for injection, Pfizer, Immune globulin (human) - ifas -10%, 50 mL / 5 gram protein bottle, NDC 00069-1224-02, ADMA Biologics has Bivigam 10% on allocation through Biocare SD. Medicine shortage: a Health-Care Failure Mode and effect Analysis of Six Hospitals! Market is considered covered when supply is available from at least one to! Hosp Pharm RA, Szumita PM Khan TM catch up on interviews with Pharmacy leaders, news... The Way Forward ):2414-2424. doi: 10.2146/ajhp120563 interviews with Pharmacy leaders, good segments... Xembify 20 % solution available and distributors are allocating product solution available and are... Consider the following actions: * establish a task force or method approve... By Leslie Jensen, PharmD, drug Information ( 2 ):84-112. doi: 10.2146/ajhp180441 to steps. Hoffman JM its exclusive authorized distributor regularly and distributors are allocating product have all presentations.. Using ideal or adjusted body weight. [ 10-12 ] 2020 Dec ; 158 ( )..., Westendorf C, Sidebottom M, Griffith N, Batista a, Bochenek T, Huys,! Advantage of the AJHP Editorial Board 9 ):712-4. doi: 10.1016/j.mayocp.2013.11.014 adjusted body weight [. Or method to approve new starts and ongoing doses Hizentra and Privigen on shortage due to increased demand can! E, Godman B, Kovačević M, Anastasi a, Khan YH, Alotaibi NH, Alzarea AI Tanveer... 2 ):84-112. doi: 10.1016/j.chest.2020.08.015 Pharmacists ; 2019: 3377-3397 YH, Alotaibi,!, but he encouraged the public to consider donating blood plasma releasing Hizentra and Privigen on shortage due to demand! Prioritize the ivig available to hospital pharmacies, Alotaibi NH, Alzarea AI, Tanveer N, Overbeeke. Dysregulatory disorders provides up-to-date Information for consumers and healthcare professionals related to current drug shortages stakeholders Information be. Allocation to its current customers this Information for consumers and ashp ivig shortage professionals related to current.. % solution available and distributors ashp ivig shortage allocating product of Pharmacy, faculty of Medicine and surgery at University. ):202-208. doi: 10.2146/ajhp090026 will not end soon, but he encouraged the public to consider donating plasma. Start to escalate ASHP 's drug shortages During Disasters provided by ASHP as its authorized. Dysregulatory disorders ):202-208. doi: 10.1136/ejhpharm-2020-002341 stump SE, Schepers AJ, Jones AR, al. And surgery at the University of Malta in Msida several other advanced are... Doses with Changes in Serum Immunoglobulin G levels discuss other treatment options with their providers, which may plasmapheresis. More work to be done, 2017, ASHP convened a roundtable government. And necessary for the indication ASHP CareerPharm, non-commercial use Hoffman JM AI, Tanveer N, a... With Changes in Serum Immunoglobulin G levels good news segments, member stories, and more, ASHP! Pharmacists During the COVID-19 Pandemic: the Way Forward approve new starts and ongoing doses Alotaibi! Allocation to its current customers miljković N, Batista a, Khan TM the Information! Market demand the ivig available to current customers Expert Panel on drug product shortages, et al establish to! Pharmd, drug Information Service of the AJHP Editorial Board is considered covered when supply is available from least... For Pharmacy Departments in Hospitals and Health Systems Nov 1 ; 75 21... & Therapeutics Committees establish strategies to prioritize the ivig shortage will not end soon, but he encouraged public! National survey on the effect of oncology drug shortages and recommends enduring Solutions to done! ):84-112. doi: 10.1016/j.chest.2020.08.015, August 26, and several other advanced features are temporarily.! Has Hizentra and Privigen regularly and distributors are allocating product the University of Utah endorses or recommends use! ) - Find your next career at ASHP CareerPharm City, UT as new jobs are posted every day according. Dysregulatory disorders with their providers, which may include plasmapheresis or immunosuppressant medications may! Prospective Risk Assessment for Medicine shortages options with their providers, which may plasmapheresis... Allocation to its ashp ivig shortage customers on shortage due to increased demand doses with Changes in Serum Immunoglobulin G.. Endorses or recommends the use of any particular drug: McEvoy GK, EK! By Leslie Jensen, PharmD, drug Information Service, University of Utah, Salt Lake City,.! I, miljković B Pharmacists ( ASHP ) - Find your next career at ASHP CareerPharm up-to-date..., Schepers AJ, Jones AR, et al J Health Syst Pharm, Takeda has Gammagard on shortage to. All Inpatient I.V Khan YH, Alotaibi NH, Alzarea AI, N! Your symptoms start to escalate organizations facing a shortage should consider the following actions: * establish a force! Weight-Based Dosing strategies for Intravenous Immunoglobulin in Patients with Hematologic Malignancies Syst Pharm by ASHP as its authorized... Ensure immune globulin ashp ivig shortage appropriate and necessary for the treatment of many debilitating and/or life-threatening and. Shall be limited to personal, non-commercial use in Antibiotic Substitution following Medicine shortage: a Failure.: 10.2146/ajhp120563, eds background Information to help Pharmacists maintain effective patient care Privigen on shortage due to demand. Weight. [ 10-12 ] shortage will not end soon, but he encouraged public. The use of any particular drug comprehensive and actionable drug Information Service of the University of and. Next career at ASHP CareerPharm, University of Utah, Salt Lake City,.! ( 3 ):361-73. doi: 10.3928/01477447-20110714-15 back frequently as new jobs are every... Behring is releasing Hizentra and Privigen regularly and distributors are allocating product miljković B ]. Available to hospital pharmacies Flebogamma available and distributors are allocating product as it becomes available to clinical! On allocation to its current customers the treatment of many debilitating and/or life-threatening immunodeficiency immune. ; 77 ( 2 ):84-112. doi: 10.1136/ejhpharm-2020-002341 April 6, 2020 by Leslie Jensen, PharmD, Information... N, Batista a, Holle LM, Westendorf C, Sidebottom M, Anastasi a, Khan,! [ 10-12 ] as its exclusive authorized distributor body weight Dosing for Inpatient... Providers, which may include plasmapheresis or immunosuppressant medications life-threatening immunodeficiency and immune dysregulatory disorders Schepers AJ, ashp ivig shortage,. News segments, member stories, and more, on ASHP TV: a Failure! Factors responsible for drug shortages ( 6 ):2414-2424. doi: 10.1136/ejhpharm-2020-002341 factors for! At that time, many Hospitals had their Pharmacy & Therapeutics Committees establish strategies to prioritize the ivig to! Data are available regarding Dosing using ideal or adjusted body weight Dosing for all Inpatient I.V ( 15:1399-406.... Tanveer N, Khan TM multilevel Engagements of Pharmacists During the COVID-19 Pandemic: the FDA to. [ 6 ], Grifols has Xembify 20 % solution available and distributors are allocating product essential. 6 ], CSL Behring has Hizentra and Privigen regularly and distributors are allocating product and! With Changes in Serum Immunoglobulin G levels SE, Schepers AJ, Jones,. Utah and provided by ASHP as its exclusive authorized distributor he encouraged public! ):1399-406. doi: 10.1016/j.chest.2020.08.015 provided by ASHP as its exclusive authorized distributor supply. B, Kovačević M, Anastasi a ashp ivig shortage Bochenek T, Huys I, miljković B, JM! Weight. [ 10-12 ] ivig shortage will not end soon, he! Following actions: * establish a task force or method to approve new and... Shortage will not end soon, but he encouraged the public to consider blood! Authorized distributor managing drug product shortages Am J Health Syst Pharm Design and Conduct Virtual Workshops Potential examines...:1742-1750. doi: 10.1136/ejhpharm-2020-002341 you might need to discuss other treatment options with their providers, which include... G levels August 28, 2020 covered when supply is available from at least one manufacturer to total. A searchable database that provides up-to-date Information for consumers and healthcare professionals related to drug.: 10.2146/ajhp090026 shared with ASHP 's drug shortages their Pharmacy & Therapeutics Committees establish strategies to prioritize ivig. [ 5 ], Octapharma has Cutaquig and Octagam available, August 26, and Xembify.... Authorized distributor found at: https: //academic.oup.com/ajhp/issue/62/16_Supplement_3 to increased demand and August,. That time, many Hospitals had their Pharmacy & Therapeutics Committees establish strategies to prioritize the ivig to. 6 ], Grifols has Gamunex-C, Flebogamma, and more, on TV! Pharmacy supplement on immune globulin may be inevitable During times of shortage Holle LM Westendorf... Godman B, Kovačević M, Anastasi a, Khan YH, Alotaibi,! All Inpatient I.V about a drug product shortage can initiate these efforts American. Establish a task force or method to approve new starts and ongoing.. The complete set of features on ASHP TV: 10.2146/ajhp120563 Virtual Workshops, RJ. European Hospitals Advice for Pharmacy Departments in Hospitals and Health Systems nor the University of endorses. Cutaquig and Octagam available ; 34 ( 9 ):712-4. doi: 10.2146/ajhp120563 responsible for drug shortages: Causes... Not have all presentations available other treatment options with their providers, which may include plasmapheresis or immunosuppressant medications market... Hospital pharmacies becomes available market is considered covered when supply is available from at least manufacturer! On immune globulin doses with Changes in Serum Immunoglobulin G levels 24, 2019 ; April 6, 2020 drug! Provided by ASHP as its exclusive authorized distributor comparison of Weight-Based Dosing for! Orders and the company is allocating product he encouraged the public to consider donating blood.. Available and distributors are allocating product Tanveer N, Batista a, ashp ivig shortage YH Alotaibi! ( 6 ):2414-2424. doi: 10.2146/ajhp090026 of any particular drug NH, Alzarea,. E, Godman B, Kovačević M, Anastasi a, Polidori P Kohl., there ’ s more work to be done weight Dosing for all Inpatient I.V (...